Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00577577
What this trial is testing

Safety and Efficacy Study of Recombinant Human Insulin-Like Growth Factor-I/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 (rhIGF-I/rhIGFBP-3) In Myotonic Dystrophy Type 1

Who this might be right for
Myotonic Dystrophy Type 1
Insmed Incorporated 69
Early research (Phase 1)Study completedNCT01032681
What this trial is testing

EMD 521873 in Advanced Solid Tumors, MTD Finding

Who this might be right for
Non-Hodgkin Lymphoma
Merck KGaA, Darmstadt, Germany 66
Not applicableStudy completedNCT05644730
What this trial is testing

Closed Loop Glucose Control in Patients With Type 1 and Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Ideal Medical Technologies 7
Testing effectiveness (Phase 2)Study completedNCT01733407
What this trial is testing

L-Serine Supplementation in Hereditary Sensory Neuropathy Type 1

Who this might be right for
Hereditary Sensory and Autonomic Neuropathy Type I
Massachusetts General Hospital 18
Testing effectiveness (Phase 2)Ended earlyNCT04544007
What this trial is testing

A Phase II Trial of Poly-ICLC for Low-Grade Gliomas

Who this might be right for
NF1Low-grade Glioma
University of Alabama at Birmingham 3
Early research (Phase 1)Ended earlyNCT04855136
What this trial is testing

Safety and Efficacy of bb2121 (Ide-cel) Combinations in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 21
Early research (Phase 1)Active Not RecruitingNCT05236036
What this trial is testing

Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of Glioblastoma

Who this might be right for
AstrocytomaGlioblastomaGlioblastoma, IDH-Wildtype+2 more
Northwestern University 86
Not applicableStudy completedNCT03976271
What this trial is testing

Consequences of Hypoglycaemia on Cardiovascular and Inflammatory Responses

Who this might be right for
HypoglycemiaInflammatory ResponseDiabetes Mellitus, Type 1+1 more
Radboud University Medical Center 110
Testing effectiveness (Phase 2)Active Not RecruitingNCT00392353
What this trial is testing

Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia

Who this might be right for
Acute Erythroid LeukemiaAcute Megakaryoblastic LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome+6 more
National Cancer Institute (NCI) 135
Early research (Phase 1)Study completedNCT00646139
What this trial is testing

KX2-391 in Treating Patients With Advanced Solid Tumors or Lymphoma That Did Not Respond to Treatment

Who this might be right for
LymphomaLymphoproliferative DisorderSmall Intestine Cancer+1 more
Roswell Park Cancer Institute 7
Testing effectiveness (Phase 2)Study completedNCT04969601
What this trial is testing

Anti-Covid-19 Vaccine in Children With Acute Leukemia and Their Siblings

Who this might be right for
Acute LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia
Assistance Publique - Hôpitaux de Paris 76
Testing effectiveness (Phase 2)Looking for participantsNCT06622434
What this trial is testing

New Adjuvant Vaccine in Glioblastoma, a Phase 1/2a Study

Who this might be right for
Newly Diagnosed Glioblastoma
Assistance Publique - Hôpitaux de Paris 35
Large-scale testing (Phase 3)Looking for participantsNCT06217302
What this trial is testing

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

Who this might be right for
Diabetic NephropathiesKidney Failure, ChronicDiabetes Mellitus Type 1+1 more
Alessandro Doria 150
Early research (Phase 1)Study completedNCT06219902
What this trial is testing

Learn if Elinzanetant Affects the Ability to Drive and Brain Function in Healthy Women

Who this might be right for
Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and MenHot Flashes
Bayer 64
Early research (Phase 1)Study completedNCT00073281
What this trial is testing

Islet Transplantation for Patients With Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 10
Testing effectiveness (Phase 2)Looking for participantsNCT07537400
What this trial is testing

Patients Between the Ages of 12 Months to 21 Years With Newly-Diagnosed High-Risk Neuroblastoma Will Receive Children's Oncology Group (COG) Type Recommended Therapy With the Addition of Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) to Induction Cycles 1-5

Who this might be right for
High-Risk Neuroblastoma
Shaare Zedek Medical Center 10
Not applicableLooking for participantsNCT06236100
What this trial is testing

Evaluating an Adverse Childhood Experience-Targeting Advocate Model of a Substance Use Prevention Program

Who this might be right for
Substance-Related DisordersAdverse Childhood Experiences
RTI International 360
Not applicableUnknownNCT05315037
What this trial is testing

Resistance Training in Type 1 Diabetes Mellitus

Who this might be right for
Type 1 Diabetes
University of Louisville 15
Not applicableStudy completedNCT00786019
What this trial is testing

Influence of Endothelial Function on Central and Peripheral Causes Of Exercise Impairment in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
University of Colorado, Denver 47
Not applicableUnknownNCT02269865
What this trial is testing

Children's Health Research Institute(CHRI), Stanford Lucile Packard Children Hospital (LPCH) Protocol on Myotonic Dystrophy

Who this might be right for
Myotonic Dystrophy Type 1
Stanford University 40
Next Page